Giovanni Filardo v. Baylor Scott and White Health

CourtCourt of Appeals of Texas
DecidedAugust 18, 2023
Docket05-21-01066-CV
StatusPublished

This text of Giovanni Filardo v. Baylor Scott and White Health (Giovanni Filardo v. Baylor Scott and White Health) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Giovanni Filardo v. Baylor Scott and White Health, (Tex. Ct. App. 2023).

Opinion

Affirm and Opinion Filed August 18, 2023

S In The Court of Appeals Fifth District of Texas at Dallas No. 05-21-01066-CV

GIOVANNI FILARDO, Appellant V. BAYLOR SCOTT AND WHITE HEALTH, Appellee

On Appeal from the 116th Judicial District Court Dallas County, Texas Trial Court Cause No. DC-20-18611

MEMORANDUM OPINION Before Chief Justice Burns, Justice Molberg, and Justice Reichek Opinion by Chief Justice Burns Giovani Filardo appeals a summary judgment disposing of his claims against

his former employer Baylor Scott & White Health for discrimination, retaliation, and

hostile work environment. We affirm.

I. BACKGROUND1

Dr. Filardo is an Italian-born American. After obtaining a Ph.D. at Yale

University, Dr. Filardo was hired at Baylor Scott & White Health in 2004 as an

1 Writing this opinion presents an unusual problem because in this appeal from a summary judgment, most of the summary judgment record is under a sealing order that we must respect. Kartsotis v. Bloch, 503 S.W.3d 506, 510 (Tex. App.—Dallas 2016, pet. denied). However, we also must hand down epidemiologist. In 2008, he helped found Baylor Health’s epidemiology department

and was appointed director of the department. In 2013, he was again promoted, this

time to an endowed chair position for cardiovascular epidemiology.

In 2017, Dr. Filardo successfully secured a $12.8 million grant from the

National Institute of Health for Baylor Health to enroll participants in a nationwide,

multiyear study called “All of Us.” Externally, Baylor Health was to coordinate its

efforts as part of a consortium of four healthcare networks that spanned seven states,

and the leader of this consortium was Henry Ford Health System. Internally, Dr.

Filardo’s efforts were to be coordinated with Baylor Scott & White Research

Institute. Dr. Filardo was appointed as Baylor Health’s principal investigator for the

study.

It is undisputed that under Dr. Filardo’s leadership, Baylor Health’s

enrollment efforts thrived. Dr. Filardo established numerous sites for the study

across Texas. Baylor Health recruited far more participants than other members of

the consortium and was in the top 5% of all participating groups in the country.

There was also evidence that Dr. Filardo devised innovative staffing methods to

which the success was partially attributable.

a public opinion explaining our decisions based on the record. See TEX. R. APP. P. 47.1, 47.3. Accordingly, we have attempted to preserve the confidentiality of the information and have made some references deliberately vague to avoid disclosing confidential details. See MasterGuard, L.P. v. Eco Techs. Int’l LLC, 441 S.W.3d 367, 371 (Tex. App.—Dallas 2013, no pet.). –2– However, internally, there were complaints about Dr. Filardo’s management

style. Dr. Filardo was described by both his peers and subordinates as territorial,

aggressive, and unprofessional. According to Baylor Research’s COO Jaime

Walkowiak, there were also reports of deviations from study protocol.

In one complaint from 2016, a subordinate raised a number of red flags about

Dr. Filardo’s management, saying he often berated, threatened, and retaliated against

staff to the point that they quit or requested transfers, he handled performance

evaluations arbitrarily, and he compensated for a lack of personal diligence by

making unreasonable demands of his staff. We detail this complaint more fully

below. This employee requested a transfer away from Dr. Filardo’s team.

In November 2017, Dr. Filardo’s immediate supervisor, Dr. Andrew Masica,

counseled him about his manner. According to Dr. Masica’s memo from the

meeting, Dr. Filardo defended his style, saying that a certain level of assertiveness

was necessary to keep the study on track. Dr. Masica reminded him that conducting

research as the principal investigator was a privilege conditioned on professional,

collaborative behavior and cautioned Dr. Filardo that he needed to avoid negative

interactions with his colleagues.

In December 2017 and January 2018, Baylor Health management received

two more complaints concerning Dr. Filardo’s behavior. In one, another of Dr.

Filardo’s employees criticized his unprofessional, rude, and demeaning behavior and

relayed an anecdote in which a doctor had advised Dr. Filardo to go easier on his

–3– team, but Dr. Filardo demurred, saying aggression was simply a byproduct of his

personality and was a necessary expedient to success in the study. Another

complaint came from the CFO of Baylor Health, who narrated how when she had

attempted to talk to Dr. Filardo about regulatory compliance problems that could

have jeopardized funding for the study, Dr. Filardo reacted in an angry and

unprofessional fashion.

On February 1, 2018, Dr. Masica and Walkowiak held a meeting with Dr.

Filardo to address the complaints. Dr. Filardo reacted on February 4, 2018, by

sending a strongly worded email to Baylor Health’s human resources department in

which he objected to Baylor Research’s interference with his efforts on the study.

He also protested what he viewed as unfair and vague accusations of bad behavior,

saying these accusations were likely rooted in prejudice against and stereotypes

about Italian men, especially since Dr. Masica had made what Dr. Filardo described

as “light hearted” jokes about Italians in the past.

On February 7, 2018, Dr. Masica again met with Dr. Filardo to discuss his

management, including what Dr. Masica described as his aggressive interaction

style, his refusal to comply with policy, and his efforts to prevent any other managers

or departments from shaping the study except himself. When pressed about his

behavior, Dr. Filardo again stated that this was simply his personality and that he

was reluctant to change because he was concerned it would compromise the project’s

success.

–4– The reports concerning Dr. Filardo subsided until an April 2019 conference

call, when he reportedly yelled threats that he would fire whomever had reported an

issue concerning documentation. The call led to a human resources investigation, in

which three out of the eight witnesses to the call confirmed accusations regarding

Dr. Filardo’s hostility on the call and his general pattern of behavior, though five

witnesses reported that the call was normal.

Another of Dr. Filardo’s subordinates filed a complaint in May 2019. She

reported being asked to manage ten worksites at once, and thus business at the sites

was handled primarily by poorly trained interns without supervision, and the interns

did not seem to understand the importance of following study protocol. This

employee took issue with Dr. Filardo’s harshness, saying team members were afraid

to bring issues to him for fear of retaliation, and he was “constantly pointing fingers.”

She requested transfer to another department.

Later in May 2019, Dr. Masica again met with Dr. Filardo to counsel him. In

a June 2019 performance review, Dr. Masica praised Dr. Filardo’s enrollment efforts

and ability to innovate, though he rated Dr. Filardo three out of five in most other

categories and again noted his “intense and difficult” interactions with others.

According to Dr. Masica,, in November 2019 Baylor Health management

informed him of a plan to execute a strategic reorganization eliminating his entire

department, and the positions held by Dr. Filardo, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bodenheimer v. PPG Industries, Inc.
5 F.3d 955 (Fifth Circuit, 1993)
Kelly v. Boeing Petroleum Services, Inc.
61 F.3d 350 (Fifth Circuit, 1995)
Evans v. The City of Houston
246 F.3d 344 (Fifth Circuit, 2001)
Laxton v. Gap Inc.
333 F.3d 572 (Fifth Circuit, 2003)
Nasti v. CIBA Specialty Chemicals Corp.
492 F.3d 589 (Fifth Circuit, 2007)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
O'Shea v. Yellow Technology Services, Inc.
185 F.3d 1093 (Tenth Circuit, 1999)
Williams v. CSX Transportation Co.
643 F.3d 502 (Sixth Circuit, 2011)
Alfano v. Costello
294 F.3d 365 (Second Circuit, 2002)
Kenneth D. Sandstad v. Cb Richard Ellis, Inc.
309 F.3d 893 (Fifth Circuit, 2002)
Hoffmann-La Roche Inc. v. Zeltwanger
144 S.W.3d 438 (Texas Supreme Court, 2004)
City of Waco v. Lopez
259 S.W.3d 147 (Texas Supreme Court, 2008)
AutoZone, Inc. v. Reyes
272 S.W.3d 588 (Texas Supreme Court, 2008)
Timpte Industries, Inc. v. Gish
286 S.W.3d 306 (Texas Supreme Court, 2009)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
Jackson v. Cal-Western Packaging Corp.
602 F.3d 374 (Fifth Circuit, 2010)
McCoy v. City of Shreveport
492 F.3d 551 (Fifth Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Giovanni Filardo v. Baylor Scott and White Health, Counsel Stack Legal Research, https://law.counselstack.com/opinion/giovanni-filardo-v-baylor-scott-and-white-health-texapp-2023.